Evidence vs experience in neonatal practices in necrotizing enterocolitis

Journal of Perinatology

Volumn 28, Issue , 2008, Pages S9-S13

  Hunter, C J ^a   Podd, B ^a   Ford, H R ^a   Camerini, V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bacteria; Inflammation; Intestinal epithelial barrier; Necrotizing enterocolitis; Prematurity; Probiotic bacteria

Indexed keywords

ANTIBIOTIC AGENT; DEXAMETHASONE; IMMUNOGLOBULIN A; INDOMETACIN; PROBIOTIC AGENT; STEROID;

ABDOMINAL RADIOGRAPHY; ASSISTED VENTILATION; BIRTH WEIGHT; BREAST FEEDING; CONFERENCE PAPER; CYANOTIC HEART DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENDOTRACHEAL INTUBATION; ENTERIC FEEDING; FLUID RESUSCITATION; GESTATIONAL AGE; HIRSCHSPRUNG DISEASE; HUMAN; HYPOVOLEMIA; IMMUNE DEFICIENCY; INFECTION RISK; INTESTINE FLORA; INTESTINE INJURY; INTESTINE INTUSSUSCEPTION; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; INTESTINE VOLVULUS; LIVER FAILURE; MECONIUM ILEUS; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN CARE; NEWBORN MORTALITY; NEWBORN SEPSIS; PANETH CELL; PARENTERAL NUTRITION; PERINATAL PERIOD; PNEUMATOSIS INTESTINALIS; PNEUMOPERITONEUM; POLYCYTHEMIA; POLYMORPHONUCLEAR CELL; PREMATURITY; RISK ASSESSMENT; RISK FACTOR; SHORT BOWEL SYNDROME; STOMACH EXAMINATION;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; ENTEROCOLITIS, NECROTIZING; EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTENSIVE CARE, NEONATAL; INTESTINAL PERFORATION; PROBIOTICS; PROFESSIONAL COMPETENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESUSCITATION;

EID: 43049143051     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.43     Document Type: Article

References (39)

1. Stoll BJ. Epidemiology of necrotizing enterocolitis. Clin Perinatol 1994; 21: 205–218.
2. Maayan-Metzger A, Itzchak A, Mazkereth R, Kuint J. Necrotizing enterocolitis in full-term infants: case–control study and review of the literature. J Perinatol 2004; 24: 494–499.
3. Berseth CL. Feeding strategies and necrotizing enterocolitis. Curr Opin Pediatr 2005; 17: 170–173.
4. Holman RC, Stoll BJ, Clarke MJ, Glass RI. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 1997; 87: 2026–2031.
5. Blakely ML, Lally KP, McDonald S, Brown RL, Barnhart DC, Ricketts RR, et al., NEC Subcommittee of the NICHD Neonatal Research Network. Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD Neonatal Research Network. Ann Surg 2005; 241: 984–989; discussion 989–994.
6. Ladd AP, Rescorla FJ, West KW, Scherer LR, Engum SA, Grosfeld JL. Long-term follow-up after bowel resection for necrotizing enterocolitis: factors affecting outcome. J Pediatr Surg 1998; 33: 967–972.
7. Aschner JL, Deluga KS, Metlay LA, Emmens RW, Hendricks-Munoz KD. Spontaneous focal gastrointestinal perforation in very low birth weight infants. J Pediatr 1988; 113: 364–367.
8. Tatekawa Y, Muraji T, Imai Y, Nishijima E, Tsugawa C. The mechanism of focal intestinal perforations in neonates with low birth weight. Pediatr Surg Int 1999; 15: 549–552.
9. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, et al., National Institute of Child Health and Human Development Neonatal Research Network. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344: 95–101.
10. Litwin A, Avidor I, Schujman E, Grunebaum M, Wilunsky E, Wolloch Y et al. Neonatal intestinal perforation caused by congenital defects of the intestinal musculature. Am J Clin Pathol 1984; 81: 77–80.
11. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 h) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 1998; 3: CD001146.
12. Okuyama H, Kubota A, Oue T, Kuroda S, Ikegami R, Kamiyama M. A comparison of the clinical presentation and outcome of focal intestinal perforation and necrotizing enterocolitis in very-low-birth-weight neonates. Pediatr Surg Int 2002; 18: 704–706.
13. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr 2003; (Suppl 9): 48–55.
14. Sakata H, Yoshioka H, Fujita K. Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur J Pediatr 1985; 144: 186–190.
15. Isolauri E, Salminen S. Probiotics, gut inflammation and barrier function. Gastroenterol Clin North Am 2005; 34: 437–450.
16. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Ferna´ ndez-Sueiro JL et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180: 2359–2364.
17. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ. T cell receptoralpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997; 150: 91–97.
18. Coates EW, Karlowicz MG, Croitoru DP, Buescher ES. Distinctive distribution of pathogens associated with peritonitis in neonates with focal intestinal perforation compared with necrotizing enterocolitis. Pediatrics 2005; 116: e241–e246.
19. Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997; 156: 145–166.
20. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1: 113–118.
21. Salzman NH, Polin RA, Harris MC, Ruchelli E, Hebra A, Zirin-Butler S et al. Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 1998; 44: 20–26.
22. Carr R. Neutrophil production and function in newborn infants. Br J Haematol 2000; 110: 18–28.
23. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, DeBruyere M. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992; 13: 215–218.
24. Mayer L. Mucosal immunity. Pediatrics 2003; 111: 1595–1600.
25. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187: 1–7.
26. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006; 368: 1271–1283.
27. Chan KL, Saing H, Yung RW, Yeung YP, Tsoi NS. A study of pre-antibiotic bacteriology in 125 patients with necrotizing enterocolitis. Acta Paediatr 1994; 396(suppl): 45–48.
28. Bury RG, Tudehope D. Enteral antibiotics for preventing necrotising enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev 2000; 4: CD000405.
29. Bury RG, Tudehope D. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev 2001; 3: CD000405.
30. Schmolzer G, Urlesberger B, Haim M, Kutschera J, Pichler G, Ritschl E et al. Multi-modal approach to prophylaxis of necrotizing enterocolitis: clinical report and review of literature. Pediatr Surg Int 2006; 22: 573–580.
31. Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999; 103: 1150–1157.
32. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990; 336: 1519–1523.
33. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999; 3: 197–202.
34. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147: 192–196.
35. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1–4.
36. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli F. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82: 103–108.
37. Caffarelli C, Bernasconi S. Preventing necrotising enterocolitis with probiotics. Lancet 2007; 369: 1578–1580.
38. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115: 178–181.
39. Ledoux D, Labombardi VJ, Karter D. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin’s disease. Int J STD AIDS 2006; 17: 280–282.